Health Canada has concluded its assessments regarding fatal adverse reactions following plasma donations in Winnipeg, determining no direct connection between the donation process and the deaths. The findings come after investigations into two separate incidents.

Investigation Findings

Health Canada spokesperson Mark Johnson stated that no link has been established between the plasma donations and the deaths. Further inquiries were directed to Manitoba’s chief medical examiner. Stephanie Holfeld, executive director of the Manitoba examiner’s office, confirmed agreement with Health Canada’s findings.

An autopsy was performed in one case, while the second case was thoroughly investigated and did not require an autopsy due to the established cause and manner of death. Manitoba Health Minister Uzoma Asagwara affirmed the province’s acceptance of the independent findings and the decision regarding the second autopsy.

Focus on Public Education

Mx. Asagwara emphasized the tragic nature of the deaths and the need to provide answers to families and Manitobans. The government will now prioritize educating Manitobans about the safety of plasma donations to enable informed decision-making.

Grifols Under Scrutiny & New Conditions

Spanish pharmaceutical company Grifols, Canada’s primary commercial plasma collector, has faced increased scrutiny following the confirmation of the deaths by Health Canada. The regulator was notified of the deaths on October 25, 2025, and January 30, 2026, at separate Winnipeg locations.

Health Canada inspectors relied on assessments from the manufacturer and Grifols regarding the machines used during the donations. The machines were quarantined by Grifols. Health Canada has imposed new conditions on Grifols’ operating licenses due to recurring systemic deficiencies at its sites.

Review of Plasmapheresis Machines

Health Canada’s review of records, including the manufacturer’s assessment, determined no action was required, and the plasmapheresis machines were not seized. The imposed conditions aim to enhance safety and operational standards at Grifols’ plasma collection sites.

Calls for Further Investigation

Kat Lanteigne, a Toronto-based advocate for publicly managed blood systems, has called for a formal inquiry into Grifols’ operations and the donor deaths. Lanteigne stated that a thorough forensic investigation was not conducted by Health Canada. She also highlighted concerns regarding high-frequency plasma donation and its potential adverse health impacts.

One of the deceased has been identified as a 22-year-old international student at the University of Winnipeg. The incidents have prompted calls for greater transparency and stricter oversight of plasma collection practices.